Created on Tuesday, 05 Nov 2019. Posted in Costing
From April 2020, the NIHR’s online interactive Costing Tool (iCT) will be the only system available for industry costing submissions for new studies. There will be no further Excel templates produced after this time.
All NHS R&D Departments are encouraged to pro-actively work ahead of this deadline and register themselves with group CPMS accounts so that are able to receive new iCT requests from our commercial partners, meaning that negotiation timelines and setup are reduced to a minimum.
Created on Tuesday, 14 May 2019. Posted in Costing | Industry
The NIHR has launched a new web-based costing tool for industry - which will enable faster and more efficient costing and contracting between the life sciences sector and the NHS during the study set-up phase. The online iCT will complement the existing Excel-based Industry Costing Template and both will continue to be available through the NIHR CRN Study Support Service Early Contact and Engagement service.
Created on Tuesday, 09 Apr 2019. Posted in Costing | Funding
There has been a question about the amount by which applications may vary in cost between Stage 1 and Stage 2 and a perception that costs should not vary by more than 10%. The official position is now that “It is accepted that a variance in costs is likely to occur between Stage 1 and Stage 2, but costs at each stage should represent value for money. Advisory committees may provide project specific costing guidance/feedback following stage 1.”
Created on Monday, 09 Apr 2018. Posted in Costing
Working out the costings for an NIHR grant should be done with experts in the leading institution where the money will be held, but if you want an overview of what kinds of things can be costed into a bid and how accurate your costings are expected to be then take a look at the NIHR's finance document.
Created on Tuesday, 31 Oct 2017. Posted in Design Tips | Costing
You need to be thinking about costing from the earliest stages of your project design. You should aim to contact the relevant Research Support Office(s), and Trust R&D offices, several weeks before the deadline and to have familiarised yourself with the current research costing guidance.
Consider the questions:
Attributing the costs of health and social care Research and Development (AcoRD)
The AcoRD guidance categorises the costs associated with research based on the nature of the activity and whether activities contribute to NHS patient care. Activities are divided into three categories, to which all research and development activities can be attributed:
A list of common research activities attributed using AcoRD are found in Annex A https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/351185/AcoRD_Annex_A_-__List_of_Common_research_Activities_March_2013_for_publication.pdf
Costings Flowchart
Created on Monday, 25 Apr 2016. Posted in Literature | Costing
An very good introduction to cost-utility analysis for those wanting to gain a better understanding of one of the most widely-used form of economic evaluation in healthcare. Full article
Created on Monday, 01 Feb 2016. Posted in Public Involvement | Costing
There are a number of ways to recognise the contributions of members of the public who are actively involved in research. This INVOLVE resource links to guides and practical advice on payment and non-monetary methods for recognising the time, skills and expertise provided by members of the public.
Created on Monday, 23 Nov 2015. Posted in Costing | Toolkit/Database
The value of Excess Treatment Costs is not a large sum in the context of overall NHS funding but anecdotal evidence suggests that the (non) payment of Excess Treatment Costs has become a point of friction between providers and commissioners.
Excess Treatment Costs are the difference between the total treatment costs and the cost of standard treatment.
Excess Treatment Costs are part of treatment costs and therefore normal commissioning arrangements apply.
This new guidance on meeting Excess Treatment Costs relates specifically to non-commercial research (i.e. research funded by the NIHR, other areas of central Government including Research Councils, NIHR noncommercial Partners and also Investigator-initiated, commercial-collaborative studies (Industry-funded, non-industry sponsored studies).
It covers the following topics:
Created on Monday, 10 Aug 2015. Posted in Public Involvement | Costing
The national NIHR patient and public advisory group INVOLVE have developed a new resource to help with budgeting for the costs of public involvement in research. The involvement cost calculator can be used for everything from putting together an involvement budget for an entire study to working out how much it will cost to run a one-off consultation event.
Created on Thursday, 29 Jan 2015. Posted in Public Involvement | Costing
New confidential service launched today 29 January 2015
Who is the Benefits Advice service for?
The National Institute for Health Research (NIHR) is offering this confidential service to:
INVOLVE is funding this service on behalf of, and for the NIHR. Other partners who are also part of the service are: